A state-of-the-science overview of randomized controlled trials evaluating acute management of moderate-to-severe traumatic brain injury

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Moderate-to-severe traumatic brain injury (TBI) remains a major global challenge, with rising incidence, unchangingmortality and lifelong impairments. State-of-the-science reviews are important for research planning and clinical decisionsupport. This review aimed to identify randomized controlled trials (RCTs) evaluating interventions for acute managementof moderate/severe TBI, synthesize key RCT characteristics and findings, and determine their implications on clinicalpractice and future research. RCTs were identified through comprehensive database and other searches. Key characteristics,outcomes, risk of bias, and analysis approach were extracted. Data were narratively synthesized, with a focus onrobust (multi-center, low risk of bias, n > 100) RCTs, and three-dimensional graphical figures also were used to explorerelationships between RCT characteristics and findings. A total of 207 RCTs were identified. The 191 completed RCTsenrolled 35,340 participants (median, 66). Most (72%) were single center and enrolled less than 100 participants (69%).There were 26 robust RCTs across 18 different interventions. For 74% of 392 comparisons across all included RCTs, therewas no significant difference between groups. Positive findings were broadly distributed with respect to RCT characteristics.Less than one-third of RCTs demonstrated low risk of bias for random sequence generation or allocation concealment, less than one-quarter used covariate adjustment, and only 7% employed an ordinal analysis approach.Considerable investment of resources in producing 191 completed RCTs for acute TBI management has resulted in very little translatable evidence. This may result from broad distribution of research effort, small samples, preponderance of single-center RCTs, and methodological shortcomings. More sophisticated RCT design, large multi-center RCTs in priority areas, increased focus on pre-clinical research, and alternatives to RCTs, such as comparative effectiveness research and precision medicine, are needed to fully realize the potential of acute TBI research to benefit patients.
Original languageEnglish
Pages (from-to)1 - 18
Number of pages18
JournalJournal of Neurotrauma
Volume33
Issue number16
DOIs
Publication statusPublished - 2016

Keywords

  • clinical trial
  • review
  • traumatic brain injury

Cite this

@article{3a32da751e7442d694e7514ab1d0d14a,
title = "A state-of-the-science overview of randomized controlled trials evaluating acute management of moderate-to-severe traumatic brain injury",
abstract = "Moderate-to-severe traumatic brain injury (TBI) remains a major global challenge, with rising incidence, unchangingmortality and lifelong impairments. State-of-the-science reviews are important for research planning and clinical decisionsupport. This review aimed to identify randomized controlled trials (RCTs) evaluating interventions for acute managementof moderate/severe TBI, synthesize key RCT characteristics and findings, and determine their implications on clinicalpractice and future research. RCTs were identified through comprehensive database and other searches. Key characteristics,outcomes, risk of bias, and analysis approach were extracted. Data were narratively synthesized, with a focus onrobust (multi-center, low risk of bias, n > 100) RCTs, and three-dimensional graphical figures also were used to explorerelationships between RCT characteristics and findings. A total of 207 RCTs were identified. The 191 completed RCTsenrolled 35,340 participants (median, 66). Most (72{\%}) were single center and enrolled less than 100 participants (69{\%}).There were 26 robust RCTs across 18 different interventions. For 74{\%} of 392 comparisons across all included RCTs, therewas no significant difference between groups. Positive findings were broadly distributed with respect to RCT characteristics.Less than one-third of RCTs demonstrated low risk of bias for random sequence generation or allocation concealment, less than one-quarter used covariate adjustment, and only 7{\%} employed an ordinal analysis approach.Considerable investment of resources in producing 191 completed RCTs for acute TBI management has resulted in very little translatable evidence. This may result from broad distribution of research effort, small samples, preponderance of single-center RCTs, and methodological shortcomings. More sophisticated RCT design, large multi-center RCTs in priority areas, increased focus on pre-clinical research, and alternatives to RCTs, such as comparative effectiveness research and precision medicine, are needed to fully realize the potential of acute TBI research to benefit patients.",
keywords = "clinical trial, review, traumatic brain injury",
author = "Peter Bragge and Anneliese Synnot and Maas, {Andrew I R} and Menon, {David K} and Cooper, {Jamie James} and Rosenfeld, {Jeffrey Victor} and Gruen, {Russell Lindsay}",
year = "2016",
doi = "10.1089/neu.2015.4233",
language = "English",
volume = "33",
pages = "1 -- 18",
journal = "Journal of Neurotrauma",
issn = "0897-7151",
publisher = "Mary Ann Liebert Inc",
number = "16",

}

TY - JOUR

T1 - A state-of-the-science overview of randomized controlled trials evaluating acute management of moderate-to-severe traumatic brain injury

AU - Bragge, Peter

AU - Synnot, Anneliese

AU - Maas, Andrew I R

AU - Menon, David K

AU - Cooper, Jamie James

AU - Rosenfeld, Jeffrey Victor

AU - Gruen, Russell Lindsay

PY - 2016

Y1 - 2016

N2 - Moderate-to-severe traumatic brain injury (TBI) remains a major global challenge, with rising incidence, unchangingmortality and lifelong impairments. State-of-the-science reviews are important for research planning and clinical decisionsupport. This review aimed to identify randomized controlled trials (RCTs) evaluating interventions for acute managementof moderate/severe TBI, synthesize key RCT characteristics and findings, and determine their implications on clinicalpractice and future research. RCTs were identified through comprehensive database and other searches. Key characteristics,outcomes, risk of bias, and analysis approach were extracted. Data were narratively synthesized, with a focus onrobust (multi-center, low risk of bias, n > 100) RCTs, and three-dimensional graphical figures also were used to explorerelationships between RCT characteristics and findings. A total of 207 RCTs were identified. The 191 completed RCTsenrolled 35,340 participants (median, 66). Most (72%) were single center and enrolled less than 100 participants (69%).There were 26 robust RCTs across 18 different interventions. For 74% of 392 comparisons across all included RCTs, therewas no significant difference between groups. Positive findings were broadly distributed with respect to RCT characteristics.Less than one-third of RCTs demonstrated low risk of bias for random sequence generation or allocation concealment, less than one-quarter used covariate adjustment, and only 7% employed an ordinal analysis approach.Considerable investment of resources in producing 191 completed RCTs for acute TBI management has resulted in very little translatable evidence. This may result from broad distribution of research effort, small samples, preponderance of single-center RCTs, and methodological shortcomings. More sophisticated RCT design, large multi-center RCTs in priority areas, increased focus on pre-clinical research, and alternatives to RCTs, such as comparative effectiveness research and precision medicine, are needed to fully realize the potential of acute TBI research to benefit patients.

AB - Moderate-to-severe traumatic brain injury (TBI) remains a major global challenge, with rising incidence, unchangingmortality and lifelong impairments. State-of-the-science reviews are important for research planning and clinical decisionsupport. This review aimed to identify randomized controlled trials (RCTs) evaluating interventions for acute managementof moderate/severe TBI, synthesize key RCT characteristics and findings, and determine their implications on clinicalpractice and future research. RCTs were identified through comprehensive database and other searches. Key characteristics,outcomes, risk of bias, and analysis approach were extracted. Data were narratively synthesized, with a focus onrobust (multi-center, low risk of bias, n > 100) RCTs, and three-dimensional graphical figures also were used to explorerelationships between RCT characteristics and findings. A total of 207 RCTs were identified. The 191 completed RCTsenrolled 35,340 participants (median, 66). Most (72%) were single center and enrolled less than 100 participants (69%).There were 26 robust RCTs across 18 different interventions. For 74% of 392 comparisons across all included RCTs, therewas no significant difference between groups. Positive findings were broadly distributed with respect to RCT characteristics.Less than one-third of RCTs demonstrated low risk of bias for random sequence generation or allocation concealment, less than one-quarter used covariate adjustment, and only 7% employed an ordinal analysis approach.Considerable investment of resources in producing 191 completed RCTs for acute TBI management has resulted in very little translatable evidence. This may result from broad distribution of research effort, small samples, preponderance of single-center RCTs, and methodological shortcomings. More sophisticated RCT design, large multi-center RCTs in priority areas, increased focus on pre-clinical research, and alternatives to RCTs, such as comparative effectiveness research and precision medicine, are needed to fully realize the potential of acute TBI research to benefit patients.

KW - clinical trial

KW - review

KW - traumatic brain injury

UR - http://online.liebertpub.com/doi/pdf/10.1089/neu.2015.4233

UR - https://www.ncbi.nlm.nih.gov/pubmed/26711675

U2 - 10.1089/neu.2015.4233

DO - 10.1089/neu.2015.4233

M3 - Article

VL - 33

SP - 1

EP - 18

JO - Journal of Neurotrauma

JF - Journal of Neurotrauma

SN - 0897-7151

IS - 16

ER -